VistaGen TherapeuticsVTGN 
$3.700.82%24h
0.82%24h
Global rank21366
Market cap$25.75M
Change 7d3.35%
YTD Performance-26.73%
SP500 benchmarkUnderperform
P/E-0.43
P/S-113.29
Revenue-$227.30K
Earnings-$59.25M
Dividend yield-
Main Sector
Healthcare
Category
VistaGen Therapeutics (VTGN) Total Liabilities
VTGN Total Liabilities in 2022: $9.01M
According to VistaGen Therapeutics latest financial reports the total liabilities of VTGN is $9.01M, an decrease of -9.26% to 2022. At the end of 2022 company had $9.93M total liabilities. This figure represents the company's financial obligations and debts, including loans, accounts payable, and other liabilities that VistaGen Therapeutics is responsible for during its operational activities.
VistaGen Therapeutics (VTGN) Total Liabilities History from 2023 to 2022
-
Value:-
VTGN Total Liabilities by year
| Year | Total liabilities | Change |
|---|---|---|
| 2023 | $9.01M | -9.26% |
| 2022 | $9.93M | -39.10% |
| 2021 | $16.30M | 41.74% |
| 2020 | $11.50M | 136.18% |
| 2019 | $4.87M | - |
View the Top Total Liabilies Stocks
